Olympus Corporation (OLYMY)

Market Cap	14.36B
Revenue (ttm)	6.32B
Net Income (ttm)	532.62M
Shares Out	n/a
EPS (ttm)	0.46
PE Ratio	26.97
Forward PE	n/a
Dividend	0.13 (1.07%)
Ex-Dividend Date	Mar 28, 2025

Volume	3,152
Average Volume	227,122
Open	12.68
Previous Close	12.51
Day's Range	12.50 - 12.68
52-Week Range	11.13 - 19.69
Beta	0.59
RSI	45.87
Earnings Date	May 13, 2025

About Olympus

Olympus Corporation manufactures and sells precision machineries and instruments worldwide. It operates through: Endoscopic Solutions Business, Therapeutic Solutions Business, Scientific Solutions Business, and Others segments. The Endoscopic Solutions Business segment offers gastrointestinal and surgical endoscopy systems, surgical microscopes, endoscope reprocessors, and maintenance services. The Therapeutic Solutions Business segment provides urology, gynecology, respiratory, ear, nose, and throat products; GI endo-therapy and energy devices...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1919
• Employees: 28,838
• Stock Exchange: OTCMKTS
• Ticker Symbol: OLYMY

Financial Performance

In 2023, Olympus's revenue was 936.21 billion, an increase of 6.16% compared to the previous year's 881.92 billion. Earnings were 242.57 billion, an increase of 69.12%.

Financial numbers in JPY